Interface Biologics' Series A Round

Interface Biologics raised a round of funding on January 10, 2011.

Interface Biologics is a commercial stage privately held company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices. IBI's primary te…

Articles about Interface Biologics' Series A Round: